UNSPSC 51402305: Metanopirone or tandospirone

This classification denotes a serotonin agonist with the molecular structure C21H29N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 190230I669 chemically known as (1r*,2s*,3r*,4s*)-n-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-2,3-norbornanedicarboximide but generally known as tandospirone, which bears US NIH Compound Identifier 60558. European Medicines Agency schedules Tandospirone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10829MIG.

The term TANDOSPIRONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, no. 3, 1989, list 29. ). Metanopirone or tandospirone bears US NLM identifiers UMLS ID C0074676 and NCI Concept Code C87208. SMILES: C1CC2CC1C3C2C(=O)N(C3=O)CCCCN4CCN(CC4)C5=NC=CC=N5.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.

UNSPSC 51402305 Metanopirone or tandospirone is a Commodity code with minimal recent state and local procurement activity. The single recent opportunity posted under this code—Seminole County, Florida's IFB60459723LAS—does not align with the code's nominal pharmaceutical scope; the solicitation seeks naloxone and safe drug deactivation systems, products unrelated to metanopirone or tandospirone. This mismatch suggests either a tagging error in the source record or that the code does not reflect actual purchasing patterns in state and local procurement. The code shows no identifiable recent activity beyond this single misaligned record and should be treated as dormant for business development purposes.

No representative opportunities in the actual scope of metanopirone or tandospirone procurement appear in the available recent-opportunities record. Firms evaluating pursuit under this code should verify whether state and local bodies are tagging such purchases correctly in their procurement systems or whether demand exists at all outside federal healthcare procurement channels.